SCHEMBL15517296

SCHEMBL15517296

CCOc1ncnc2ccc(-c3cn[nH]c3)cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACVR1 Q04771 1/20 0.51
PIM1 P11309 1/20 0.50
PIM3 Q86V86 1/20 0.50
PIM2 Q9P1W9 1/20 0.50
MAP4K4 O95819 1/20 0.45
GRK2 P25098 5/20 0.45
GRK5 P34947 2/20 0.45
GRK1 Q15835 1/20 0.45
ROCK2 O75116 5/20 0.44
AKT1 P31749 2/20 0.42
RAF1 P04049 1/20 0.42
BRAF P15056 1/20 0.42
AURKA O14965 1/20 0.42
PRKCB P05771 1/20 0.42
GRK6 P43250 1/20 0.42
ROCK1 Q13464 1/20 0.42
CAMK2B Q13554 1/20 0.42
RPS6KA1 Q15418 1/20 0.42
GRK7 Q8WTQ7 1/20 0.42
MELK Q14680 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3336157 0.81 ROCK2 (0.49) ACVR1PIM1PIM3PIM2GRK2
SCHEMBL3334866 0.79 MAP4K4 (0.57) MAP4K4RAF1BRAFCYP1A2CYP2C9
SCHEMBL13874691 0.77 MAP4K4 (0.60) ACVR1PIM1PIM3PIM2MAP4K4
SCHEMBL3334925 0.77 PIK3CD (0.58) MAP4K4RAF1BRAF
SCHEMBL14595786 0.73 IRAK4 (0.48) MAP4K4CYP1A2CYP2C9CYP2C19RAB9A
SCHEMBL4357306 0.73 CYP1A2 (0.52) ACVR1PIM1PIM3PIM2MAP4K4
SCHEMBL2621728 0.72 RAB9A (0.47) MAP4K4CYP1A2CYP2C9CYP2C19RAB9A
SCHEMBL3865271 0.72 HTT (0.56) CYP1A2CYP2C9CYP2C19RAB9A
SCHEMBL3338478 0.72 RAB9A (0.56) MAP4K4RAF1BRAFCYP1A2RAB9A
SCHEMBL3848789 0.72 ACVR1 (0.47) ACVR1PIM1PIM3PIM2GRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8673929-B2 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections GILEAD SCIENCES, INC. (US) 2014-03-18 US claimed